Disease Overview：Coronary artery disease（CAD）
Coronary artery disease (CAD), commonly known as coronary heart disease, is a chronic condition characterized by the narrowing or blockage of the coronary arteries due to atherosclerotic plaque buildup. This impairs myocardial perfusion, leading to angina pectoris, myocardial infarction, arrhythmias, or heart failure. Risk factors include hypertension, dyslipidemia, diabetes mellitus, smoking, sedentary lifestyle, and genetic predisposition. Diagnosis relies on electrocardiography, stress testing, echocardiography, coronary computed tomography angiography (CCTA), and invasive coronary angiography. Management encompasses pharmacotherapy (antiplatelets, statins, beta-blockers, ACE inhibitors), lifestyle modification, percutaneous coronary intervention (PCI) with drug-eluting stents, and coronary artery bypass grafting (CABG) for multivessel or left main disease.
China offers distinct advantages for CAD treatment: its top-tier cardiovascular centers—many accredited by JCI or ISO—employ internationally trained interventional cardiologists and cardiac surgeons with extensive experience in complex PCI, robotic-assisted CABG, and hybrid revascularization. Advanced imaging modalities (e.g., intravascular ultrasound, optical coherence tomography) and next-generation stents are routinely utilized. Clinical outcomes align with global benchmarks: multi-center studies report 30-day mortality post-CABG below 2.5% and 12-month target lesion revascularization rates under 8%. Crucially, costs for comprehensive CAD care—including diagnostics, PCI, or CABG—are typically 40–60% lower than in the US or Western Europe, without compromising safety or efficacy.
As a dedicated medical tourism agency, we facilitate seamless access to these high-quality services for international patients. We coordinate hospital referrals, verify physician credentials, provide itemized, transparent pricing in advance, arrange visa support and accommodation, and assign bilingual care coordinators for end-to-end assistance—from pre-travel consultation through post-discharge follow-up.
Coronary artery disease: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Coronary Artery Disease (CAD)
Non-Surgical / Conservative Management
*Target criteria:* Stable angina, low SYNTAX score (<22), no high-risk features (e.g., LVEF <40%, recurrent ischemia on meds).
- •Core Medications (30-day supply, tiered pricing):
- *Tier 2 (Branded domestic):* Aspirin (¥15), Atorvastatin (¥45), Metoprolol (¥62), Nitrate (¥78) → Total: ¥200 (~$28) - *Tier 3 (Imported):* Clopidogrel (¥198), Rosuvastatin (¥220), Rivaroxaban (if indicated, ¥310) → Total: ¥728 (~$102)
- •Essential Diagnostics (per episode):
- Echocardiogram (TTE): ¥320 ($45) - Stress test (treadmill ECG): ¥450 ($63) - Coronary CTA (64-slice): ¥1,200 ($169)
Surgical / Interventional Procedures
*Eligibility:* ≥70% stenosis in ≥1 major epicardial vessel, unstable angina/NSTEMI/STEMI, SYNTAX score ≥22 or left main disease.
- •PCI (Percutaneous Coronary Intervention):
- *Multi-vessel:* +¥15,000–¥25,000 ($210–$350) per additional stent - *Pre-op workup:* Coronary angiography (¥8,500/$1,195), renal function panel (¥120/$17), coagulation profile (¥95/$13)
- •CABG (Coronary Artery Bypass Grafting):
- Off-pump or arterial grafts: +¥20,000–¥35,000 ($280–$490) - Pre-op: Cardiopulmonary exercise test (¥1,200/$169), CT angiography (¥1,200/$169), carotid ultrasound (¥380/$53)
Special/Complex Condition Management
- •Left Main CAD or severe multivessel disease with diabetes/LVEF <35%: CABG preferred; cost range ¥105,000–¥145,000 ($1,475–$2,040) including ICU stay (¥2,800/day).
- •Chronic Total Occlusion (CTO): PCI with specialized equipment (microcatheters, IVUS): +¥18,000–¥32,000 ($250–$450) over standard PCI.
- •Refractory angina (no revascularization option): Enhanced External Counterpulsation (EECP): ¥12,000/course (20 sessions, $169).
Quick Selection Guide
- •<65 years, high SYNTAX, no comorbidities: CABG (long-term survival advantage; budget ≥$1,500).
- •65–75 years, single-vessel, moderate budget ($500–$1,000): Domestic-stent PCI + Tier 2 meds.
- •>75 years, frail, multiple comorbidities (COPD, CKD): Conservative management (Tier 1 meds + stress test monitoring; budget <$100).
- •STEMI within 90 min of arrival: Immediate PCI (imported stent justified; total cost ~$1,200–$1,500 including angiography and ICU).
- •Diabetes + multivessel CAD: CABG over PCI (superior 5-year outcomes; allocate $1,600+).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Coronary artery disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Coronary artery disease treatment with China top medical destinations:
